Cancer Treatment Reviews

Published by: Elsevier Inc.  

People

  1. Jhaveri
    Jhaveri
  2. Tap
    Tap
  3. Drilon
    Drilon
  4. O'Reilly
    O'Reilly
  5. Cheung
    Cheung
  6. Hudis
    Hudis
  7. Ilson
    Ilson
  8. Kemeny
    Kemeny
  9. Modi
    Modi
  10. Sacchini
    Sacchini

Groups

  1. Department of Medicine (35)
  2. Solid Tumor Oncology Division (33)
  3. Breast Medicine Service (9)
  4. Gastrointestinal Oncology Service (9)
  5. Hematologic Malignancies, Division of (5)
  6. Surgery (5)
  7. Thoracic Oncology (5)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
  9. Center for Pancreatic Cancer Research (4)
  10. GSK Faculty (4)
Search Within
Formats
  1. Journal Article (25)
  2. Review (24)
  3. Meeting Abstract (5)
  4. Guidelines (2)
Groups
  1. Department of Medicine (35)
  2. Solid Tumor Oncology Division (33)
  3. Breast Medicine Service (9)
  4. Gastrointestinal Oncology Service (9)
  5. Hematologic Malignancies, Division of (5)
  6. Surgery (5)

More Groups

People
  1. Bruce Minsky (5)
  2. Komal Jhaveri (4)
  3. William Tap (4)
  4. Alexander Drilon (3)
  5. Eileen O'Reilly (3)
  6. Clifford Hudis (2)

More People

Years
  1. 2025 (5)
  2. 2024 (3)
  3. 2023 (6)
  4. 2022 (6)
  5. 2021 (1)
  6. 2020 (3)

More Years

Publishers
  1. Elsevier Inc. (56)

Results (56)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers
    Review

    Stacchiotti, S.; Pantziarka, P.; Leonard, H.; Voltz, C.; Abatedaga, L.; Bouche, G.; Bouygues, C.; Bovée, J. V. M. G.; van der Graaf, W. T. A.; Rojas, T. D.; more...
    Cancer Treatment Reviews (2025)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitor-related neurotoxicity: Incidence and management. A systematic review and meta-analysis
    Review

    Nielsen, D. L.; Juhl, C. B.; Chen, I. M.; Wang, Y.; Nielsen, O. H.; Santomasso, B. D.
    Cancer Treatment Reviews (2025)

    Fulltext@MSK | Save
  • Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group
    Review

    Corso, G.; Shen, S.; Criscitiello, C.; Mukhtar, R.; Gamble, L.; Rocco, E. G.; Pesapane, F.; Nicosia, L.; Jhaveri, K.; Salimbeni, B. T.; more...
    Cancer Treatment Reviews (2025)

    Fulltext@MSK | Save
  • Tepotinib in patients with MET exon 14 skipping non-small cell lung cancer
    Review

    Paik, P. K.; Iams, W. T.; Husain, H.; O'Hara, R. M. Jr; Adewusi, E.; Le, X.
    Cancer Treatment Reviews (2025)

    Fulltext@MSK | Save
  • Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapy
    Review

    Knafler, G.; Ho, A. L.; Moore, K. N.; Pollack, S. M.; Navenot, J. M.; Sanderson, J. P.
    Cancer Treatment Reviews (2025)

    Fulltext@MSK | Save
  • NTRK gene fusion testing and management in lung cancer
    Review

    Repetto, M.; Chiara Garassino, M.; Loong, H. H.; Lopez-Rios, F.; Mok, T.; Peters, S.; Planchard, D.; Popat, S.; Rudzinski, E. R.; Drilon, A.; more...
    Cancer Treatment Reviews (2024)

    Fulltext@MSK | Save
  • Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer
    Review

    Jhaveri, K.; Marmé, F.
    Cancer Treatment Reviews (2024)

    Fulltext@MSK | Save
  • MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of action
    Review

    Somaiah, N.; Tap, W.
    Cancer Treatment Reviews (2024)

    Fulltext@MSK | Save
  • Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
    Review

    Perissinotti, A. J.; Bishop, M. R.; Bubalo, J.; Geyer, M. B.; Goodrich, A.; Howard, S. C.; Kula, J.; Mandayam, S.; Cairo, M. S.; Pui, C. H.
    Cancer Treatment Reviews (2023)

    Fulltext@MSK | Save
  • Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?
    Review

    Haddad, R. I.; Harrington, K.; Tahara, M.; Szturz, P.; Le Tourneau, C.; Salmio, S.; Bajars, M.; Lee, N. Y.
    Cancer Treatment Reviews (2023)

    Fulltext@MSK | Save

    • Cancer Treatment Reviews – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Treatment Reviews 0305-7372 W.B. Saunders Co.
    Cancer treatment reviews 15321967 Unknown
    Cancer Treatment Reviews 0305-7372 Elsevier Inc.
    Cancer Treatment Reviews 0305-7372 Elsevier Inc.
    Cancer Treatment Reviews 0305-7372 Elsevier Ltd
    Cancer Treatment Reviews 03057372 Elsevier Inc.
    Cancer Treatment Reviews 0305-7372 Elsevier Inc.
    Cancer Treatment Reviews 03057372 2025
    Cancer Treatment Reviews 03057372 2014
    Cancer Treatment Reviews 0305-7372 Elsevier Science, Inc.
    Cancer Treatment Reviews 0305-7372 Unknown
    Cancer Treatment Reviews 03057372 The Authors
    Cancer Treatment Reviews 03057372 Unknown
    Cancer Treatment Reviews 03057372 2023
    Cancer Treatment Reviews 03057372 Elsevier Inc.
    Cancer Treatment Reviews 03057372 The Author(s)
    Cancer Treatment Reviews 0305-7372 W.B. Saunders Co.
    Cancer Treatment Reviews 03057372 Elsevier B.V.
    Cancer Treatment Reviews 03057372 1995
    Cancer Treatment Reviews 0305-7372 Elsevier Inc.
    Cancer Treatment Reviews 0305-7372 2014
    Cancer Treatment Reviews 03057372 2022